mir-218 microRNA precursor family

mir-218 microRNA precursor family
Predicted secondary structure and sequence conservation of mir-218
Identifiers
Symbol mir-218
Rfam RF00255
miRBase MI0000294
miRBase family MIPF0000026
Other data
RNA type Gene; miRNA
Domain(s) Eukaryota
GO 0035195 0035068
SO 0001244

miR-218 microRNA precursor is a small non-coding RNA that regulates gene expression by antisense binding.

miR-218 appears to be a vertebrate specific microRNA and has now been predicted and experimentally confirmed in a wide range of vertebrate species.[1] The extents of the hairpin precursors are not known. In this case the mature sequence in excised from the 5'arm of the hairpin.

miR-218, along with miR-585, has been found to be silenced by DNA methylation in oral squamous cell carcinoma.[2] It is also downregulated in Nasopharyngeal carcinoma, with artificially-induced expression serving to slow tumour growth.[3] miR-218 has also been found to have tumour suppressing qualities in bladder cancer cells.[4]

References

  1. "miRNA gene family: mir-218". mirBASE. The University of Manchester.
  2. Uesugi, A; Kozaki, K; Tsuruta, T; Furuta, M; Morita, K; Imoto, I; Omura, K; Inazawa, J (Sep 1, 2011). "The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer.". Cancer Research 71 (17): 5765–78. doi:10.1158/0008-5472.CAN-11-0368. PMID 21795477.
  3. Alajez, NM; Lenarduzzi, M, Ito, E, Hui, AB, Shi, W, Bruce, J, Yue, S, Huang, SH, Xu, W, Waldron, J, O'Sullivan, B, Liu, FF (Mar 15, 2011). "MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.". Cancer Research 71 (6): 2381–91. doi:10.1158/0008-5472.CAN-10-2754. PMID 21385904.
  4. Tatarano, S; Chiyomaru, T, Kawakami, K, Enokida, H, Yoshino, H, Hidaka, H, Yamasaki, T, Kawahara, K, Nishiyama, K, Seki, N, Nakagawa, M (July 2011). "miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.". International journal of oncology 39 (1): 13–21. doi:10.3892/ijo.2011.1012. PMID 21519788.

External links